Chinese english Germany Japanese Korea

3-benzyl-7-tert-butyl-2-[(2-oxo-2-phenylethyl)sulfanyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one

3-benzyl-7-tert-butyl-2-[(2-oxo-2-phenylethyl)sulfanyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one Struktur
354992-66-8
CAS-Nr.
354992-66-8
Englisch Name:
3-benzyl-7-tert-butyl-2-[(2-oxo-2-phenylethyl)sulfanyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one
Synonyma:
3-benzyl-7-tert-butyl-2-[(2-oxo-2-phenylethyl)sulfanyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one;[1]Benzothieno[2,3-d]pyrimidin-4(3H)-one, 7-(1,1-dimethylethyl)-5,6,7,8-tetrahydro-2-[(2-oxo-2-phenylethyl)thio]-3-(phenylmethyl)-
CBNumber:
CB12051988
Summenformel:
C29H30N2O2S2
Molgewicht:
502.69
MOL-Datei:
354992-66-8.mol
Request For Quotation

3-benzyl-7-tert-butyl-2-[(2-oxo-2-phenylethyl)sulfanyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one Eigenschaften

Sicherheit

3-benzyl-7-tert-butyl-2-[(2-oxo-2-phenylethyl)sulfanyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one Chemische Eigenschaften,Einsatz,Produktion Methoden

3-benzyl-7-tert-butyl-2-[(2-oxo-2-phenylethyl)sulfanyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-benzyl-7-tert-butyl-2-[(2-oxo-2-phenylethyl)sulfanyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6178 60
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6350 50
Specs --
 info@specs.net The Netherlands 6835 70
  • 3-benzyl-7-tert-butyl-2-[(2-oxo-2-phenylethyl)sulfanyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one
  • [1]Benzothieno[2,3-d]pyrimidin-4(3H)-one, 7-(1,1-dimethylethyl)-5,6,7,8-tetrahydro-2-[(2-oxo-2-phenylethyl)thio]-3-(phenylmethyl)-
  • 354992-66-8
Copyright 2019 © ChemicalBook. All rights reserved